Ropes Wealth Advisors LLC acquired a new stake in shares of Steris PLC (NYSE:STE) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 175 shares of the medical equipment provider’s stock, valued at approximately $26,000.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Fort L.P. boosted its stake in Steris by 23.6% during the 1st quarter. Fort L.P. now owns 19,561 shares of the medical equipment provider’s stock valued at $2,504,000 after acquiring an additional 3,733 shares during the last quarter. Neuburgh Advisers LLC boosted its stake in Steris by 22.5% during the 1st quarter. Neuburgh Advisers LLC now owns 11,748 shares of the medical equipment provider’s stock valued at $1,505,000 after acquiring an additional 2,156 shares during the last quarter. Texas Permanent School Fund boosted its stake in Steris by 3.9% during the 1st quarter. Texas Permanent School Fund now owns 57,433 shares of the medical equipment provider’s stock valued at $7,353,000 after acquiring an additional 2,137 shares during the last quarter. Twin Capital Management Inc. boosted its stake in Steris by 0.6% during the 1st quarter. Twin Capital Management Inc. now owns 34,440 shares of the medical equipment provider’s stock valued at $4,409,000 after acquiring an additional 200 shares during the last quarter. Finally, Kornitzer Capital Management Inc. KS bought a new position in Steris during the 1st quarter valued at $17,528,000. Hedge funds and other institutional investors own 85.45% of the company’s stock.
Steris stock opened at $151.21 on Thursday. The business has a 50-day simple moving average of $149.82. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.87 and a current ratio of 2.41. Steris PLC has a 1 year low of $99.14 and a 1 year high of $156.12. The company has a market cap of $12.81 billion, a P/E ratio of 30.92 and a beta of 0.98.
Steris (NYSE:STE) last posted its quarterly earnings results on Monday, August 5th. The medical equipment provider reported $1.23 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.11 by $0.12. Steris had a net margin of 11.22% and a return on equity of 13.80%. The company had revenue of $696.80 million for the quarter, compared to the consensus estimate of $674.12 million. During the same period last year, the firm posted $1.00 EPS. The company’s revenue for the quarter was up 9.1% on a year-over-year basis. As a group, equities analysts expect that Steris PLC will post 5.45 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Tuesday, September 10th will be given a $0.37 dividend. This is an increase from Steris’s previous quarterly dividend of $0.34. This represents a $1.48 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Monday, September 9th. Steris’s dividend payout ratio (DPR) is presently 27.81%.
In related news, CEO Walter M. Rosebrough, Jr. sold 119,000 shares of the stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $132.56, for a total value of $15,774,640.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Walter M. Rosebrough, Jr. sold 102,500 shares of the stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $151.78, for a total transaction of $15,557,450.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 355,286 shares of company stock worth $50,048,013. Insiders own 2.36% of the company’s stock.
A number of research analysts have recently issued reports on STE shares. KeyCorp raised their price target on shares of Steris from $135.00 to $138.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 15th. Stephens raised their price target on shares of Steris from $135.00 to $150.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 15th. JMP Securities raised their price target on shares of Steris from $135.00 to $150.00 and gave the stock a “market outperform” rating in a research report on Wednesday, May 22nd. Finally, Zacks Investment Research upgraded shares of Steris from a “hold” rating to a “buy” rating and set a $146.00 price target on the stock in a research report on Tuesday, April 30th. Five equities research analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and an average target price of $148.20.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Story: What is the Russell 2000 Index?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.